Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

LORAZEPAM IMPURITY D CRS (15 MG)

LORAZEPAM IMPURITY D CRS (15 MG)

NA

DISCOVER
PACLITAXEL SEMI-SYNTHETIC FORPEAK IDENTIFICATION CRS (10 MG

PACLITAXEL SEMI-SYNTHETIC FORPEAK IDENTIFICATION CRS (10 MG

33069-62-4

DISCOVER
TRIGLYCEROL DIISOSTEARATE CRS(200 MG)

TRIGLYCEROL DIISOSTEARATE CRS(200 MG)

NA

DISCOVER
MIRTAZAPINE FOR SYSTEM SUITABILITY CRS (10 MG)

MIRTAZAPINE FOR SYSTEM SUITABILITY CRS (10 MG)

61337-67-5

DISCOVER
CODEINE CRS - * NARC (CODEINEMONOHYDRATE) (25 MG)

CODEINE CRS - * NARC (CODEINEMONOHYDRATE) (25 MG)

6059-47-8

DISCOVER
THEBAINE CRS - * NARC (15 MG)

THEBAINE CRS - * NARC (15 MG)

115-37-7

DISCOVER
NORGESTIMATE CRS (10 MG)

NORGESTIMATE CRS (10 MG)

35189-28-7

DISCOVER
NORGESTIMATE FOR SYSTEM SUITABILITY CRS (5 MG)

NORGESTIMATE FOR SYSTEM SUITABILITY CRS (5 MG)

35189-28-7

DISCOVER
DORZOLAMIDE HYDROCHLORIDE CRS(50 MG)

DORZOLAMIDE HYDROCHLORIDE CRS(50 MG)

130693-82-2

DISCOVER
DORZOLAMIDE IMPURITY A CRS (5MG)

DORZOLAMIDE IMPURITY A CRS (5MG)

120279-95-0

DISCOVER
FELBINAC CRS (10 MG)

FELBINAC CRS (10 MG)

5728-52-9

DISCOVER
FELBINAC IMPURITY A CRS (20 MG)

FELBINAC IMPURITY A CRS (20 MG)

92-91-1

DISCOVER